FNY Investment Advisers’s Oragenics OGEN Stock Holding History

FNY Investment Advisers’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,500	Closed	-$9K	–	1433
2025 Q2	$9K	Buy	+2,500	New	+$12.7K	﹤0.01%	679

Other funds holding OGEN

DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FNY Investment Advisers's OGEN Position: Q3 2025 in Review

FNY Investment Advisers sold out of Oragenics (OGEN) in Q3 2025, closing a stake of 2,500 shares — an estimated $9K sold.

FNY Investment Advisers first reported a position in OGEN in Q2 2025 and held it in 1 quarter. The position peaked at $9K in Q2 2025. 16 funds tracked by Wall St. Rank hold OGEN as of Q3 2025.

FNY Investment Advisers reported no remaining Oragenics position as of Q3 2025 after selling out during the quarter.
FNY Investment Advisers sold 2,500 Oragenics shares in Q3 2025, an estimated $9K.
FNY Investment Advisers first reported a position in Oragenics in Q2 2025 and held it in 1 quarter.
FNY Investment Advisers's Oragenics position peaked at $9K in Q2 2025.
16 funds tracked by Wall St. Rank held Oragenics as of Q3 2025.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.